tiprankstipranks

Bio-Gene Technology Ends 2.5 Million Securities

Bio-Gene Technology Ends 2.5 Million Securities

Bio-Gene Technology Ltd. (AU:BGT) has released an update.

Confident Investing Starts Here:

Bio-Gene Technology Ltd. has announced the cessation of 2.5 million securities due to the expiration of options that were not exercised by December 1, 2024. This development reflects the company’s ongoing management of its issued capital, which may interest investors monitoring changes in stock availability and market dynamics.

For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1